JP2024525697A5 - - Google Patents

Info

Publication number
JP2024525697A5
JP2024525697A5 JP2024501558A JP2024501558A JP2024525697A5 JP 2024525697 A5 JP2024525697 A5 JP 2024525697A5 JP 2024501558 A JP2024501558 A JP 2024501558A JP 2024501558 A JP2024501558 A JP 2024501558A JP 2024525697 A5 JP2024525697 A5 JP 2024525697A5
Authority
JP
Japan
Prior art keywords
antigen
protein
recombinant protein
recombinant
pathogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024501558A
Other languages
English (en)
Japanese (ja)
Other versions
JP7900480B2 (ja
JP2024525697A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/069513 external-priority patent/WO2023285489A1/en
Publication of JP2024525697A publication Critical patent/JP2024525697A/ja
Publication of JP2024525697A5 publication Critical patent/JP2024525697A5/ja
Application granted granted Critical
Publication of JP7900480B2 publication Critical patent/JP7900480B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024501558A 2021-07-13 2022-07-12 鳥類における抗体干渉の克服 Active JP7900480B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21185334.6 2021-07-13
EP21185334 2021-07-13
PCT/EP2022/069513 WO2023285489A1 (en) 2021-07-13 2022-07-12 Overcoming antibody-interference in avians

Publications (3)

Publication Number Publication Date
JP2024525697A JP2024525697A (ja) 2024-07-12
JP2024525697A5 true JP2024525697A5 (cg-RX-API-DMAC7.html) 2025-09-24
JP7900480B2 JP7900480B2 (ja) 2026-08-04

Family

ID=76920583

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024501558A Active JP7900480B2 (ja) 2021-07-13 2022-07-12 鳥類における抗体干渉の克服

Country Status (6)

Country Link
US (1) US20250009868A1 (cg-RX-API-DMAC7.html)
EP (1) EP4370150A1 (cg-RX-API-DMAC7.html)
JP (1) JP7900480B2 (cg-RX-API-DMAC7.html)
CN (1) CN117881422A (cg-RX-API-DMAC7.html)
MX (1) MX2024000544A (cg-RX-API-DMAC7.html)
WO (1) WO2023285489A1 (cg-RX-API-DMAC7.html)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961982A (en) 1985-09-06 1999-10-05 Syntro Corporation Recombinant herpesvirus of turkeys and uses thereof
FR2749022B1 (fr) 1996-05-23 2001-06-01 Rhone Merieux Cellules aviaires immortelles
US5672485A (en) 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth
AU2007226555B2 (en) 2006-03-15 2012-07-05 Intervet International B.V. Recombinant Mononegaviral virus vectors
US8871220B2 (en) 2009-04-03 2014-10-28 Merial Limited Newcastle disease virus vectored avian vaccines
CN103370079B (zh) 2010-10-18 2016-08-10 英特维特国际股份有限公司 针对家禽中禽流感的火鸡疱疹病毒作为载体的疫苗
US9012424B2 (en) 2011-05-27 2015-04-21 20Med Therapeutics B.V. Nanogels
BR112017011582A2 (pt) 2014-12-04 2018-02-27 Intervet Int Bv fibroblasto de embrião de galinha imortalizado, cultura de célula, métodos para preparação de um cef importalizado, para a replicação de um vetor viral aviário e para a preparação de uma vacina, e, vacina.
WO2017055235A1 (en) 2015-09-30 2017-04-06 Boehringer Ingelheim Vetmedica Gmbh Improved modular antigen transportation molecules and uses therof in animals
JP7354106B2 (ja) 2017-12-04 2023-10-02 インターベット インターナショナル ベー. フェー. レプリコン粒子および油性アジュバントによるワクチン接種
WO2019121888A1 (en) 2017-12-20 2019-06-27 Intervet International B.V. Improved diluent for cell-associated alphaherpesvirus vaccine
GB202016954D0 (en) * 2020-10-26 2020-12-09 Pirbright Inst Vaccine

Similar Documents

Publication Publication Date Title
JP6375329B2 (ja) ベロ細胞において増強された複製を有する高力価の組換えインフルエンザウイルス
Mebatsion et al. Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope
JP7627911B2 (ja) 卵内複製のための安定化されたhaを持つ組換えインフルエンザウイルス
Kumar et al. RETRACTED: Evaluation of the Newcastle Disease Virus F and HN Proteins in Protective Immunity by Using a Recombinant Avian Paramyxovirus Type 3 Vector in Chickens
JP2020010711A (ja) Mdck、ベロ細胞又は卵内で増強された複製を有する高力価の組換えインフルエンザウイルス
JP2015119730A5 (cg-RX-API-DMAC7.html)
Alexander Avian Paramyxoviridae-recent developments
JP5432703B2 (ja) 組み換えモノネガウイルス目ウイルスベクター
JP2009203242A (ja) インビボ(invivo)マルチプルdnaワクチンと多価dnaワクチン
EP1930026B1 (en) A method for generating infectious bursal disease virus from synthetic RNA transcripts
Rezaei et al. Influenza virus-like particle containing two different subtypes of hemagglutinin confers protection in mice against lethal challenge with A/PR8 (H1N1) and A/HK (H3N2) viruses
AU592954B2 (en) Vaccinal polypeptides
KR102332656B1 (ko) H9 헤마글루티닌을 포함하는 뉴캐슬병 재조합 벡터 및 이로부터 제조된 재조합 바이러스
RU2024103267A (ru) Преодоление интерференции антител у птиц
KR20250067065A (ko) 재조합 sfts 바이러스 기반 2가 백신 조성물
JP2022546813A5 (cg-RX-API-DMAC7.html)
CN104357460B (zh) 重组鸭病毒性肠炎病毒、制备方法和应用
JP2024518548A5 (cg-RX-API-DMAC7.html)
Panshin et al. Variability of antigenic epitopes of the fusion protein of Newcastle disease virus
JP2024518548A (ja) アミノ酸、ヌクレオチドおよびそれを発現するベクター、ならびにサルベコウイルス感染症の予防におけるそれらの使用
Coleclough et al. Respiratory Vaccination of Mice Against Influenza Virus: Dissection of T‐and B‐Cell Priming Functions
RU2451027C2 (ru) Рекомбинантная вакцина против вируса "свиного" гриппа h1n1 и спсоб ее получения
KR100585279B1 (ko) 저온적응된 약독화된 인플루엔자 바이러스 및 독성인플루엔자 바이러스로부터 저온적응 특성과 약독화 특성을갖는 재조합 인플루엔자 바이러스를 제조하는 방법
CN118599874A (zh) 基于流感病毒骨架的SARS-CoV-2嵌合病毒样颗粒及构建方法
AU2004238246A1 (en) Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry